,20 We have also identified S1PR2 as an important mediator of the autonomous osteoanabolic effects of S1P in OBs and demonstrated that a pharmacological S1PR2 agonist protects against ovariectomy-induced osteopenia.9 Here, S1PR2 is linked to Osteopenia.